Phosphate oxoanions and phosphorylated biomolecules (such as nucleotides, lipids and proteins) play key roles in a wide range of biological processes. The ability to selectively detect these ions in the presence of each other has numerous applications in biochemistry and biomedicine. However, receptors and sensors that can discriminate between polyphosphate species with high selectivity and in biologically relevant conditions are rare.
Lissoclinum class of natural products were initially employed to provide an added degree of preorganization to the receptors, although it was subsequently found that short, flexible bis[Zn(II)DPA]-functionalized linear peptides are also effective scaffolds for selective pyrophosphate recognition.
The peptidic receptors were successfully employed for the detection of PPi in aqueous media by indicator displacement assays using both colorimetric and fluorescent indicators, with the best compounds able to bind to PPi selectively in both cell growth media and artificial urine and also allow the accurate determination of PPi concentrations in physiologically relevant ranges (micromolar concentrations) in these complex media.
Improved pyrophosphate selectivity was observed upon increasing the complexity of the media from HEPES buffer to cell growth media (Krebs saline).
Pyrophosphate sensors in which a fluorescent indicator was covalently attached to either a linear or cyclic peptide scaffold through a flexible linker were then constructed. When the Zn(II)DPA binding sites and the indicator were suitably placed with respect to one another on
Introduction
Anions are critical to the maintenance of life, with almost every biochemical process involving the recognition, transport or transformation of anions. This has led to growing interest in the design of artificial anion receptors for sensing applications in biochemistry and biomedicine. 1, 2 Phosphate oxoanions are of particular interest because they play crucial roles in a variety of fundamental biological processes, including genetic information storage, energy transduction, signal processing and membrane transport. For example, pyrophosphate (P2O7 4-, PPi) is released during DNA/RNA polymerase reactions, in the biosynthesis of secondary messengers such as cAMP and is a hydrolysis product of ATP. 3 PPi is also found at elevated levels in synovial fluid or urine in patients with a variety of diseases, including osteoarthritis 4, 5 and urolithiasis, 6 and abnormal intracellular PPi levels have been suggested as a tool for cancer diagnosis. 7 Therefore, the development of receptors that can distinguish between the large number of biologically occurring phosphate anions [(poly)phosphates and phosphorylated biomolecules] to bind selectively to a target ion (e.g. PPi) in physiological conditions has numerous potential bioanalytical applications.
Anions can interact with receptors through electrostatic interactions, hydrogen bonds or coordination bonds with metal ions. However, in water, anions such as PPi are highly solvated, 8 so the development of selective receptors typically requires the use of strong electrostatic interactions or coordination bonds. One of the most successful approaches to date for the recognition of phosphate oxoanions in water is the use of Zn(II)dipicolylamine (Zn (II)DPA) binding motifs, which have been found to be particularly selective towards phosphate derivatives over other anions. 9, 10 Receptors capable of discrimination between phosphate oxoanions can be prepared through the preorganisation of multiple Zn(II)DPA binding sites using an appropriate molecular scaffold. For example, receptors bearing two appropriately positioned Zn(II)DPA binding sites have been shown to bind selectively to polyphosphorylated peptides via a two-point binding interaction, 11 whereas the meta-xylyl derivative 1 12 is able to discriminate between PPi and Pi. For further examples the reader is directed to a recent review. 9 The distance between the two Zn(II) centres in these complexes is key to controlling their selectivity, since phosphate oxoanions bind to the two metal ions in a bridging mode, with one or two oxygen atoms bound to each Zn(II) centre.
While a large range of different molecular scaffolds have been employed to preorganize the Zn(II)DPA binding sites, 9 the design of receptors able to discriminate between PPi and other di-and tri-phosphate derivatives (e.g. ATP) remains a challenge. 13 We show here how our work on the use of peptidic scaffolds to position two Zn(II)DPA binding sites for anion recognition has led to the development of selective receptors for PPi that are able to function in complex media (e.g. cell growth buffers) and selectively sense PPi in the presence of high concentrations of other phosphate derivatives, including ATP.
Scaffold design
The key requirements for developing selective receptors that can bind to phosphate oxoanions in relevant conditions (aqueous solution, presence of interferants) are: 1) that the receptors complement the large size and shape of these species; 2) that binding sites are suitably positioned to discriminate between structurally similar anions and 3) that the binding sites provide sufficiently strong interactions with the target analyte for binding to occur. This mandates the use of suitably large scaffolds that position the binding elements in a complementary arrangement to the geometry of a particular guest. The use of peptides for this purpose provides a means of readily varying the size and shape of the scaffold through alteration of amino acid composition, relative stereochemistry and peptide length. One of the key advantages of peptidic scaffolds is the ability to generate libraries of receptors with subtle structural modifications to tease out the factors providing selectivity for specific anionic guests.
To circumvent the lack of defined geometry (and therefore preorganization) displayed by short, linear peptides, scaffold rigidification can be achieved through cyclization 14, 15 and additional preorganization can be achieved through the incorporation of peptide backbone modifications such as heterocycles. 16 The Lissoclinum family of cyclic peptides contains cyclic hexa-, hepta-and octa-peptides characterised by the presence of azole heterocycles alternating with proteinogenic amino acid residues. 17 A network of bifurcated hydrogen bonds between the azole nitrogen atoms and the amide protons reduces the flexibility of these compounds, providing a relatively flat macrocycle from which all amino acid side-chains project onto one face of the scaffold (if they are of the same absolute configuration) ( Figure 1 ). 18 These modified cyclic peptides, and analogues thereof, have been used as molecular scaffolds in molecular recognition, as molecular switches and in combinatorial chemistry. 15, 16, 19 They appeared an ideal starting point from which to develop selective receptors for PPi, as two Zn(II)DPA units could be positioned in a convergent manner on the peptide side chains and the peptide structure could be readily varied to introduce additional binding sites or change the positions of the Zn(II)DPA units with respect to one another. Disorder and solvent removed for clarity.
These cyclic peptide scaffolds are readily prepared via either cyclooligomerisation of an oxazole amino acid monomer [20] [21] [22] or dimer, 23 or alternatively through solution 24 or solidphase 23 peptide synthesis of a linear peptide containing the preformed azole heterocycles, followed by macrocyclization. Side chain amine groups can be deprotected and functionalized through reductive amination with picolylaldehyde, followed by complexation with Zn(II) to install the Zn(II)DPA anion binding motifs.
Anion recognition using indicator displacement assays
In order to provide a ready method for sensing anion binding events, without the need for additional synthetic effort to incorporate a chromophore or fluorophore, we initially employed indicator displacement assays (IDAs) 25 to investigate anion binding with these Zn(II)DPAfunctionalized peptides. Our first receptor, 2 (Figure 2) , was based on a cyclic octapeptide scaffold bearing two Zn(II)DPA groups at an appropriate distance to complement the size and geometry of PPi. 26 The binding affinity of 2 for indicator 3 was first determined by fluorescence titration and subsequent non-linear curve fitting of the emission data to a standard 1 : 1 binding model. The apparent association constants of 2 for anions were then determined using IDAs, using a non-linear least squares fitting procedure based on the equilibria described for competition assays. 27 In IDAs in combination with 3, 2 exhibited high affinity for PPi anions (log Ka = 8.0) under mimicked physiological conditions (pH 7.2, 5 mM HEPES buffer, 145 mM NaCl). The 2·3 chemosensing ensemble was found to display complete selectivity for PPi over monophosphate derivatives, including AMP and HPO4 2-, which were unable to displace the indicator even upon addition of a large excess of anion. Significant selectivity for PPi over ATP (log Ka = 5.9) and ADP (log Ka = 5.6) was also observed. In comparison, the use of the smaller diketopiperazine scaffold 4 30 resulted in reduced binding affinity and selectivity for PPi 7 (log Ka = 6.0 for PPi and 5.3 for ATP), suggesting that the larger scaffold is required for appropriate placement of the two Zn(II)DPA groups to develop an effective PPi sensor. Since the discrimination between PPi and ATP observed for the 2·3 chemosensing ensemble was not high enough to detect small quantities of PPi in the presence of excess ATP, we subsequently synthesised a small library of analogues (5-9) to investigate how selectivity for PPi could be improved by modifying the scaffold size, relative position of the two Zn(II)DPA groups and the steric bulk of the additional 'non-binding' side chains. 23, 29, 30 Leucine (Leu) and phenylalanine (Phe) were incorporated to increase the steric bulk of the non-binding side chains, as it was expected that this might improve selectivity for PPi over the bulkier ATP and ADP. In IDAs, using the same indicator (3) as above but under slightly different conditions (pH 7.4, 5 mM HEPES buffer), we observed differences in binding affinity for PPi of over two orders of magnitude for this library, with 9 exhibiting the highest PPi affinity (log Ka = 9.8), while 5 had the lowest affinity (log Ka = 7.2). 29 Significant differences in the ability of these receptors to discriminate between PPi and ATP were also observed. In contrast to our expectations, for the series 2, 5, 6 in which the steric bulk of the non-binding side chains was varied, it was found that the smaller methyl side chains of the alanine (Ala) derivative 2 provided better selectivity for PPi over ATP and ADP than the more bulky and hydrophobic Leu (5) and Phe (6) analogues. In the case of the Phe derivative 6, slightly higher affinity for ATP (log Ka = 8.6) than PPi (log Ka = 8.4) was observed, with molecular modelling suggesting that the increased affinity for ATP results from a secondary p-p stacking interaction of one of the Phe side chains with the adenine moiety ( Figure 3 ), whereas the Leu derivative 5 was unable to discriminate between PPi, ATP and ADP (log Ka = 7.4 -7.6 for all three anions). Moving the Zn(II)DPA binding sites next to each other on the peptide scaffold (7, 8) also produced improved selectivity for PPi over ATP and ADP. Reduction of the size of the peptide scaffold to a hexapeptide (9) resulted in higher binding affinities for both PPi and ATP than the analogous octapeptide 7 (with similar discrimination between these two anions), even though the Zn(II)DPA binding sites are positioned the same distance apart in these two systems.
Similar trends in the binding affinities were observed upon increasing the ionic strength of the media to better mimic physiological conditions (pH 7.4, 5 mM HEPES buffer, 145 mM NaCl) ( Table 1 ). These results suggested that both the size and positioning of the non-binding side chains could be used to tune the properties of these receptors to provide improved discrimination of PPi from ATP and other similar polyphosphate derivatives. We subsequently evaluated the effect of changing the indicator in the IDA on binding selectivity, using a series of colorimetric indicators and a modified library of receptors (2, 10-16) in which the distance between the Zn(II)DPA groups and the cyclic peptide scaffold was varied, with Ala 'non-binding' side chains incorporated to favour PPi binding as determined above. 30 We had previously observed that decreasing the distance between the scaffold and anion binding sites significantly improved anion recognition for hydrogen-bonding receptors based on similar scaffolds, 31 and reasoned that bringing the Zn(II)DPA sites closer to the peptide scaffold might provide additional hydrogen-bonding interactions between the anion and the peptide backbone amides. We found that receptors with shorter side chains (10, 11 and 13) exhibited improved selectivity for PPi and that the cyclic tetraoxazoles provided better PPi selectivity than the smaller cyclic trioxazole scaffold. (Table 1) , with the best selectivity observed when 19 was employed as the indicator ( Figure 6 ). As observed previously, selectivity for PPi over other species was significantly improved in Krebs buffer ( Table 2 ) as compared to HEPES buffer, allowing the accurate detection of PPi concentrations from 1-36 µM in the presence of 250 µM ATP (Fig.   7 ). In contrast, while receptor 1 also exhibits high affinity for PPi in an IDA using 17 in Krebs saline, the ability of the 1·17 ensemble to discriminate between PPi, ATP and ADP is considerably lower than that of the cyclic peptide derivatives, illustrating the importance of the peptide scaffold in obtaining selective binding. In contemporaneous studies, we evaluated the ability of linear peptides bearing two Zn(II)DPA binding sites adjacent to each other or with a spacing 'non-binding' amino acid (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (Figure   8 ) to selectively discriminate between phosphate oxoanions in IDAs with 17. 32 While these short linear peptides lack the preorganisation of the cyclic derivatives described above, their synthesis can be achieved entirely on solid phase, greatly simplifying the production of receptor libraries. We prepared a library of receptors incorporating a variety of side chains on the spacer amino acid. Despite their lack of preorganization, linear peptides bearing two Zn(II)DPA binding sites on the side chains were found to display high affinities and a distinct selectivity for di-and tri-phosphate derivatives (e.g. PPi, ATP, ADP) over monophosphates (e.g. AMP, HPO4 2-, phosphorylated amino acids) in IDAs with indicator 17 (pH 7.4, 5 mM HEPES buffer, 145 mM NaCl) ( Table 1 ). In all cases PPi was observed to bind with higher affinity than ATP or ADP and the introduction of non-binding side chains had observable effects on both selectivity and affinity, with the presence of hydrophobic residues providing enhanced affinity for both PPi and ATP. Receptors 28 and 29 with aromatic groups (e.g. Trp, Nal) on the spacer amino acid side chain were found to have increased selectivity for PPi over ATP, presumably due to steric clashes with the larger ATP anion. Alteration of the Zn(II) DPA binding sites on short peptide scaffolds was also evaluated, with the introduction of a triazole moiety to provide an additional coordination site for each Zn(II) centre (30, 31) ( Figure 9 ). 33 These compounds bound to 17 in a similar manner to the 'standard' Zn(II)DPA complexes (32, 33) and were employed in IDAs to evaluate anion binding. In Krebs saline, similar anion binding trends were observed for compounds with and without the additional triazole unit, although slightly higher affinities and selectivities for PPi were found for compounds containing the triazole ligands (30, 31) A further series of linear peptides (34) (35) (36) (37) (38) was then evaluated in Krebs saline (Figure 8 ). 34 As previously observed for the cyclic peptide receptors, reducing the length of the side chains from four (Lys, 34) to two (Dab, 36) methylene units resulted in increased affinity for PPi and enhanced selectivity for PPi over ATP ( Table 2 ). NMR studies suggested that the increased affinity for PPi was a result of the presence of secondary hydrogen bonding interactions from the peptide backbone to the anion in addition to the coordination interactions between the anion and the Zn(II) centres ( Figure 10 Overall, we have found that in IDAs the cyclic peptide based receptors provide slightly better selectivity and affinity for PPi than the linear receptors ( Table 2 ). For both receptor classes, moving the Zn(II)DPA binding sites closer to the peptide scaffold provides improved selectivity for PPi over ATP and ADP. The effects of non-binding side chains are not as significant for the linear peptides as they are for the cyclic peptides. We attribute this to the 
Anion Recognition with covalently attached indicators
While our peptidic Zn(II)DPA receptors displayed excellent selectivity and affinity for PPi using IDAs in physiological media, including cell growth buffer and artificial urine, there are some applications for PPi sensing for which IDAs are unlikely to be viable (e.g. determination of intracellular [PPi]). We envisaged that an intramolecular IDA, 36 in which the indicator is covalently attached to the receptor via a flexible linker that allows either binding to the Zn(II) centres or displacement, would provide a novel means by which to create PPi sensors that could be used in these applications. Therefore, we covalently attached a coumarin fluorophore to two cyclic Zn(II)DPA peptide scaffolds, to provide 39 and 40 for comparison with the analogous 2·3 and 12·3 chemosensing ensembles. We also prepared a linear peptide analogue 41 with the same covalently attached indicator ( Figure 13 ). 37 Receptors 39 and 41 exhibited a large fluorescence enhancement upon addition of PPi (pH 7.4, 5 mM HEPES buffer, 145 mM NaCl, We subsequently employed 39 and 41 in the real-time monitoring of the activity of pyrophosphatase, an enzyme that catalyses hydrolysis of PPi to produce two phosphate ions.
In these assays, PPi the decrease in emission of 39 and 41 at 485 nm was monitored as PPi was consumed in the enzymatic reaction, with larger quantities of the enzyme resulting in a more rapid decrease in fluorescence, consistent with a more rapid reduction in PPi concentration in the presence of more enzyme (Figure 15 ). However, the solubility of these receptors in Krebs saline was too low to allow studies in this more competitive medium or use in determination of intracellular PPi concentrations. Given the improved selectivity observed using the intramolecular IDA approach, together with the increased PPi affinities observed for linear peptides bearing the triazole-modified Zn(II)DPA units, we combined these two structural features to provide a new series of compounds 42-45 ( Figure 13 ) and investigated their anion recognition properties. 38 
Conclusions
We have found that the use of peptidic scaffolds to position two Zn(II)DPA binding sites provides an effective method for the construction of receptors that show a remarkable ability to discriminate PPi from other polyphosphate derivatives, including nucleoside triphosphates.
Both IDAs and receptors with covalently attached indicators can be employed for the selective detection of PPi in complex media such as cell growth buffer and artificial urine. However, it remains to be seen whether these compounds will be capable of accurately sensing PPi concentrations in more complex biological samples e.g. in synovial fluid or in cells. The design of similar receptors capable of selective recognition of other polyphosphate ions, e.g. ATP, in the presence of PPi, to provide a suite of selective receptors for different phosphate species, also presents a future challenge.
